Methods of regulating expression of genes or of gene products using substituted tetracycline compounds

Details for Australian Patent Application No. 2007249695 (hide)

Owner Paratek Pharmaceuticals, Inc.

Inventors Nelson, Mark L.; Bujard, Hermann

Agent Cullen & Co

Pub. Number AU-A-2007249695

PCT Pub. Number WO2007/133797

Priority 60/800,662 15.05.06 US

Filing date 15 May 2007

Wipo publication date 22 November 2007

International Classifications

C12N 15/63 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using vectors

C12N 15/85 (2006.01) Mutation or genetic engineering - for animal cells

Event Publications

8 January 2009 PCT application entered the National Phase

  PCT publication WO2007/133797 Priority application(s): WO2007/133797

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007249696-Methods of regulating expression of genes or of gene products using substituted tetracycline compounds

2007249682-Post-operative control of cardiac arrhythmia by modification of neuronal signaling